Skye Bioscience, Inc.·4

Dec 16, 6:50 PM ET

Ward Keith Wayne 4

4 · Skye Bioscience, Inc. · Filed Dec 16, 2021

Insider Transaction Report

Form 4
Period: 2021-12-14
Transactions
  • Award

    Director Option Grant (Right to Buy)

    2021-12-14+250,000250,000 total
    Exercise: $0.06Exp: 2031-12-14Common Stock (250,000 underlying)
Footnotes (1)
  • [F1]The Option grant shall be exercisable for a price of $0.058 per Option Share for ten years from December 14, 2021 (the "Grant Date") and the Options will vest in equal monthly installments over the one year period from the Grant Date.

Documents

3 files
  • 4
    wf-form4_163969862196316.xmlPrimary

    FORM 4

  • EX-24

    211214 KEITH WARD POA

  • GRAPHIC
    a211215_kwxskyexbiox-xpo001.jpg

    211214 KEITH WARD POA